ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Respiratory Tract Diseases
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy
Conjunctivitis

Asthma trials near Washington, DC, USA:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Washington D.C., District of Columbia, United States and 87 other locations

This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Washington D.C., District of Columbia, United States and 7 other locations

This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation...

Enrolling
Asthma Acute
Combination Product: Rademikibart in prefilled syringe
Drug: Matching placebo in prefilled syringe

Phase 2

Connect Biopharm LLC

White Marsh, Maryland, United States of America and 40 other locations

This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...

Enrolling
Asthma (Diagnosis)
Drug: Placebo
Drug: WIN378

Phase 2

Windward Bio

White Marsh, Maryland, United States and 49 other locations

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Active, not recruiting
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Columbia, Maryland, United States and 155 other locations

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Active, not recruiting
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Glenn Dale, Maryland, United States and 64 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Takoma Park, Maryland, United States and 335 other locations

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Enrolling
Severe Asthma
Drug: Verekitug
Drug: Placebo

Phase 2

Upstream Bio

White Marsh, Maryland, United States of America and 56 other locations

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...

Enrolling
Asthma
Biological: NSI-8226
Biological: Placebo

Phase 2

Uniquity One (UNI)

White Marsh, Maryland, United States and 59 other locations

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Rocatinlimab

Phase 2

Amgen
Amgen

White Marsh, Maryland, United States of America and 154 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems